G1 Therapeutics Cash from Investing (TTM) Analysis

G1 Therapeutics Inc (GTHX)

3.31 0.00 (0.00%) USD | NASDAQ | May 31, 16:00

3.305 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
March 31, 2024	5.189M
December 31, 2023	2.81M
September 30, 2023	-9.905M
June 30, 2023	-46.77M
March 31, 2023	-47.62M
December 31, 2022	-50.53M
September 30, 2022	-30.17M
June 30, 2022	-0.506M
March 31, 2022	0.00
December 31, 2021	0.00
September 30, 2021	0.00
June 30, 2021	0.152M
March 31, 2021	0.152M
December 31, 2020	0.152M
September 30, 2020	-0.948M

Date	Value
June 30, 2020	-2.324M
March 31, 2020	-2.50M
December 31, 2019	-2.716M
September 30, 2019	-1.727M
June 30, 2019	-0.917M
March 31, 2019	-0.854M
December 31, 2018	-0.709M
September 30, 2018	-0.622M
June 30, 2018	-0.444M
March 31, 2018	-0.352M
December 31, 2017	-0.294M
September 30, 2017	-0.311M
June 30, 2017	-0.199M
March 31, 2017	-0.2067M
December 31, 2016	-0.25M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-50.53M

Minimum

Dec 2022

5.189M

Maximum

Mar 2024

-9.408M

Average

-0.9325M

Median

Cash from Investing (TTM) Benchmarks